Login to Your Account



Financings Roundup


Friday, March 4, 2011
Stem Cell Therapeutics Corp., of Calgary, Alberta, filed a final short-form base shelf prospectus with the securities commissions in British Columbia, Alberta, Manitoba, Ontario and Nova Scotia allowing the company to offer common shares, warrants or units for initial aggregate proceeds of up to $15 million during the next 25 months.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription